Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108440623A reveals a novel silylation-free route for Capecitabine Intermediate. Achieve higher purity and reduced manufacturing costs with scalable supply.
Novel continuous synthesis method for high-purity 3-methyl-3-butene-1-alcohol. Reduces pressure and temperature while enhancing supply chain reliability for global buyers.
Patent CN109761975B reveals a catalyst-free aminomethylation route for imidazoheteroaryls, offering significant cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed method converts tert-butyl isonitrile to amidines. Reduces costs and simplifies supply chain for pharmaceutical intermediate manufacturing.
Patent CN105273006B details a high-yield synthesis route for advanced ligands. This method ensures high purity and simplified processing for reliable pharmaceutical intermediates supply chains.
Patent CN104109174B introduces a novel ligand for asymmetric methoxycarbonylation, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Novel amide solvent method ensures high purity for Abemaciclib intermediate. Reduces impurities and simplifies supply chain for pharmaceutical manufacturing.
Patent CN114621128A reveals a novel TBS-protection strategy for (S)-oxiracetam, eliminating column chromatography to ensure >99.9% purity and significant cost reduction.
Patent CN101417910A details solid acid catalysis for prazole nitration, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed route for baloxavir intermediate. Safer, scalable, cost-effective manufacturing solution for global supply chains.
Novel palladium-catalyzed quinazolinone synthesis offers high yield and scalable production capabilities for global pharmaceutical intermediates manufacturing supply chains.
Novel one-pot synthesis for 2-arylaminoacetamide compounds reduces hazardous waste and improves safety for scalable pharmaceutical intermediate manufacturing supply chains.
Novel catalytic amination process for ethacridine reduces waste and improves purity. Ideal for pharmaceutical supply chains seeking cost-effective API manufacturing solutions.
Patent CN103408573B reveals novel NHC-catalyzed boration. Achieve cost reduction in API intermediate manufacturing with high-purity boronic acid derivatives.
Novel process for 1H-imidazo[4,5-c]quinoline-4-amine via cyano intermediates. High purity, scalable route for API manufacturing avoiding harsh conditions.
Novel palladium-copper catalytic method for phenanthrene intermediates ensures high purity and scalable production for global pharmaceutical supply chains efficiently.
Patent CN106928191B reveals improved Lansoprazole production with higher purity and yield. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel low-temperature halogenated solvent process for high-purity imidazole ester. Reduces cost and eliminates chromatography for reliable pharmaceutical intermediate supply.
Patent CN107793325A reveals a green boric acid catalyzed route for synthetic capsaicin, offering high purity and reduced environmental impact for supply chains.
Novel patent CN110878104B details a safer two-step route for chiral 1,2-bis(2,5-diphenylphosphino)ethane, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.